Abnova provides laboratory services to researchers investigating circulating tumor DNA (ctDNA) released into the peripheral blood from tumor mass of cancer patients. Our capability is supported by a streamlined platform for ctDNA extraction, purification, library preparation, and next-generation sequencing. ctDNA liquid biopsy is a precision tool for identifying and tracking cancer transformation and metastasis. It has a significant clinical impact on cancer diagnosis, prognosis, treatment, and monitoring in the new era of personalized medicine.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An interpretative report of the cancer gene mutations will be provided. | |
|
|
|
- Global : OEM@abnova.com / Japan : jutaku@funakoshi.co.jp
- TW : +886-2-8751-1888 / USA : +1(857) 639 0367 / Korea : +82-1670-5911.